Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls
Conditions: Parkinson Disease; REM Sleep Behavior Disorder; Healthy Intervention: Drug: (11C)PE2I Sponsors: Weill Medical College of Cornell University; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Iron | Neurology | Parkinson's Disease | Sleep Disorders | Sleep Medicine | Stroke